Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)
CNY 6.25
(-1.88%)
CNY 6.25
(-1.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -147.42 Million | -66.07 Million | 230.98 Million | 32.8 Million | 22.3 Million | 137.08 Million |
| Net Income | -707.33 Million | 44.57 Million | 159.33 Million | 66.29 Million | -672.11 Million | 99.62 Million |
| Depreciation & Amortization | 46.46 Million | 115.28 Million | 59.61 Million | 42.98 Million | 60.89 Million | 42.95 Million |
| Deferred income taxes | 23.33 Million | 27.22 Million | -15.49 Million | -15.28 Million | -8.09 Million | -3.46 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -236.17 Million | -351.69 Million | -119.32 Million | -118.49 Million | -551.88 Thousand | -45.32 Million |
| Other non-cash items | 61.67 Million | 125.76 Million | 131.36 Million | 42.03 Million | 634.08 Million | 39.82 Million |
| Investing Cash Flow | 64.45 Million | -62.42 Million | -454.02 Million | -160.88 Million | -4.41 Million | -395.22 Million |
| Investments in PPE | -6.79 Million | -51.47 Million | -142.26 Million | -18.82 Million | -5.23 Million | -8.83 Million |
| Acquisitions | 78.55 Thousand | - | -948.55 Million | -86.85 Million | 825.16 Thousand | 609.4 Thousand |
| Investment purchases | - | - | 13.01 Million | 1.9 Million | - | -386.99 Million |
| Sales/Maturities of investments | - | - | 501 Thousand | 345.21 | - | - |
| Other Investing Activities | 71.16 Million | -10.94 Million | 623.28 Million | -57.11 Million | 0.50 | 609.39 Thousand |
| Financing Cash Flow | 77.73 Million | 57.57 Million | 199.57 Million | -10.09 Million | -3.13 Million | 340.39 Million |
| Debt repayment | -116.16 Million | -449.55 Million | -564.09 Million | -281.96 Million | -274.5 Million | -336.5 Million |
| Dividends payments | -62.03 Million | -56.03 Million | -37.33 Million | -12.9 Million | -27.31 Million | -20.25 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 255.93 Million | 563.16 Million | 801 Million | 284.77 Million | 298.68 Million | 697.14 Million |
| Accounts receivables | -510.54 Million | 113.98 Million | -153.14 Million | -39.05 Million | -32.39 Million | -21.91 Million |
| Accounts payables | 255.75 Million | -628.78 Million | -1.52 Million | -7.37 Million | 46.43 Million | -30.11 Million |
| Inventory | -4.71 Million | 135.87 Million | 50.84 Million | -56.77 Million | -6.49 Million | 10.17 Million |
| Other working capital | 279.08 Million | 27.22 Million | -15.49 Million | -15.28 Million | -8.09 Million | -55.5 Million |
| Cash at beginning of period | 11.54 Million | 82.46 Million | 106.89 Million | 260.78 Million | 241.67 Million | 153.69 Million |
| Cash at end of period | 6.3 Million | 11.54 Million | 82.46 Million | 106.89 Million | 260.78 Million | 241.67 Million |
| Capital Expenditure | -6.79 Million | -51.47 Million | -142.26 Million | -18.82 Million | -5.23 Million | -8.83 Million |
| Effect of forex changes on cash | - | -5608.22 | -969.02 Thousand | -15.72 Million | 4.35 Million | 5.72 Million |
| Net cash flow / Change in cash | -5.23 Million | -70.92 Million | -24.42 Million | -153.89 Million | 19.1 Million | 87.97 Million |
| Free Cash Flow | -154.21 Million | -117.54 Million | 88.72 Million | 13.98 Million | 17.06 Million | 128.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -28.39 Million | -105.06 Million | -47.5 Million | -707.33 Million | -489.8 Million | -91.63 Million |
| Depreciation & Amortization | - | 10.32 Million | 10.32 Million | 46.46 Million | 46.46 Million | -21.47 Million |
| Deferred income taxes | - | - | - | 23.33 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -236.17 Million | -515.25 Million | 252.26 Million |
| Other non-cash items | 25.78 Million | 118.08 Million | 14.68 Million | 61.67 Million | 779.23 Million | -119.25 Million |
| Investing Cash Flow | 3.24 Million | -11.7 Million | -2.69 Million | 64.45 Million | 69.49 Million | -1.07 Million |
| Investments in PPE | -1.23 Million | -1.77 Million | -2.69 Million | -6.79 Million | -1.74 Million | -1.07 Million |
| Acquisitions | - | - | - | 78.55 Thousand | 76.17 Thousand | 900.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.48 Million | -9.93 Million | - | 71.16 Million | 71.24 Million | 900.00 |
| Financing Cash Flow | 694.86 Thousand | 9.05 Million | 31.5 Million | 77.73 Million | 112.62 Million | -16.05 Million |
| Debt repayment | -68.29 Million | -65.3 Million | -6.29 Million | -116.16 Million | -35.21 Million | -68.75 Million |
| Dividends payments | - | -6.8 Million | -11.64 Million | -62.03 Million | -36.99 Million | -8.54 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 68.99 Million | -56.24 Million | 49.44 Million | 255.93 Million | 184.82 Million | 61.23 Million |
| Accounts receivables | - | - | - | -510.54 Million | -510.54 Million | 174.96 Million |
| Accounts payables | - | - | - | 255.75 Million | - | - |
| Inventory | - | - | - | -4.71 Million | -4.71 Million | 77.3 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 10.06 Million | 8.55 Million | 6.3 Million | 11.54 Million | 6.56 Million | 758.31 Thousand |
| Cash at end of period | 6.73 Million | 10.06 Million | 2.31 Million | 6.3 Million | 6.3 Million | 6.56 Million |
| Capital Expenditure | -1.23 Million | -1.77 Million | -2.69 Million | -6.79 Million | -1.74 Million | -1.07 Million |
| Effect of forex changes on cash | - | 10.73 Thousand | 20.1 Thousand | - | -30.47 Thousand | 54.25 Thousand |
| Net cash flow / Change in cash | -3.32 Million | 1.51 Million | -3.98 Million | -5.23 Million | -267.75 Thousand | 5.81 Million |
| Free Cash Flow | -3.85 Million | 918.82 Thousand | -35.5 Million | -154.21 Million | -181.11 Million | 18.82 Million |
300932
ZEELEARN
605158
CIWV
002192
CNLPM